Literature DB >> 25911240

The regulation of radiosensitivity by p53 and its acetylation.

Jing Zhang1, Liangfang Shen2, Lun-Quan Sun3.   

Abstract

The p53 signaling pathway plays critical roles in determining the radio-sensitivity of normal tissues but is frequently inactivated in cancer. In various cancer cells, p53 has different effects on radio-sensitivity through complex mechanisms. Acetylation of p53 is an important means of post-translational modifications and is indispensable for its activation that is a reversible enzymatic process. Both acetylation and deacetylation of p53 are involved in the fine regulation of cellular responses to DNA damage and genotoxic stress, such as radiation. Targeting the acetylation of p53 may enable the modulation of radio-sensitivity of cancer cells.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Acetylation; P53; Posttranslational modifications; Radio sensitivity; Radiotherapy

Mesh:

Substances:

Year:  2015        PMID: 25911240     DOI: 10.1016/j.canlet.2015.04.015

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  15 in total

1.  Nicotinamide Phosphoribosyltransferase Promotes Pulmonary Vascular Remodeling and Is a Therapeutic Target in Pulmonary Arterial Hypertension.

Authors:  Jiwang Chen; Justin R Sysol; Sunit Singla; Shuangping Zhao; Aya Yamamura; Daniela Valdez-Jasso; Taimur Abbasi; Krystyna M Shioura; Sakshi Sahni; Vamsi Reddy; Arvind Sridhar; Hui Gao; Jaime Torres; Sara M Camp; Haiyang Tang; Shui Q Ye; Suzy Comhair; Raed Dweik; Paul Hassoun; Jason X-J Yuan; Joe G N Garcia; Roberto F Machado
Journal:  Circulation       Date:  2017-02-15       Impact factor: 29.690

2.  Homologs of the Tumor Suppressor Protein p53: A Bioinformatics Study for Drug Design.

Authors:  Kelly M Thayer; Claudia Carcamo
Journal:  MOJ Proteom Bioinform       Date:  2020-02-05

3.  p53-Dependent Senescence in Mesenchymal Stem Cells under Chronic Normoxia Is Potentiated by Low-Dose γ-Irradiation.

Authors:  Ines Höfig; Yashodhara Ingawale; Michael J Atkinson; Heidi Hertlein; Peter J Nelson; Michael Rosemann
Journal:  Stem Cells Int       Date:  2015-12-16       Impact factor: 5.443

4.  Distribution bias analysis of germline and somatic single-nucleotide variations that impact protein functional site and neighboring amino acids.

Authors:  Yang Pan; Cheng Yan; Yu Hu; Yu Fan; Qing Pan; Quan Wan; John Torcivia-Rodriguez; Raja Mazumder
Journal:  Sci Rep       Date:  2017-02-08       Impact factor: 4.379

5.  Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1.

Authors:  Xiahui Li; Shujing Li; Bowen Li; Yanan Li; Sattout Aman; Kangkai Xia; Yuxi Yang; Bashir Ahmad; Huijian Wu
Journal:  NPJ Precis Oncol       Date:  2021-03-19

6.  Inhibition of survivin enhances radiosensitivity of esophageal cancer cells by switching radiation-induced senescence to apoptosis.

Authors:  Xianghe Liu; Yahui Zhao; Weina Zhang; Yang Gao; Miaomiao Huo; Mei Liu; Zefen Xiao; Shufang Liang; Ningzhi Xu; Hongxia Zhu
Journal:  Onco Targets Ther       Date:  2018-05-24       Impact factor: 4.147

Review 7.  Regulating tumor suppressor genes: post-translational modifications.

Authors:  Ling Chen; Shuang Liu; Yongguang Tao
Journal:  Signal Transduct Target Ther       Date:  2020-06-10

8.  Antagonizing CD105 enhances radiation sensitivity in prostate cancer.

Authors:  Anisha Madhav; Allen Andres; Frank Duong; Rajeev Mishra; Subhash Haldar; Zhenqiu Liu; Bryan Angara; Roberta Gottlieb; Zachary S Zumsteg; Neil A Bhowmick
Journal:  Oncogene       Date:  2018-05-02       Impact factor: 9.867

9.  Abnormal accumulation of p53 predicts radioresistance leading to poor survival in patients with endometrial carcinoma.

Authors:  Azusa Akiyama; Takeo Minaguchi; Kaoru Fujieda; Yoshihiko Hosokawa; Keiko Nishida; Ayumi Shikama; Nobutaka Tasaka; Manabu Sakurai; Hiroyuki Ochi; Toyomi Satoh
Journal:  Oncol Lett       Date:  2019-09-30       Impact factor: 2.967

10.  Interleukin-1α associates with the tumor suppressor p53 following DNA damage.

Authors:  J Novak; B Zamostna; V Vopalensky; M Buryskova; L Burysek; D Doleckova; M Pospisek
Journal:  Sci Rep       Date:  2020-04-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.